Rheumatoid arthritis: FDA reporting patterns
111,586 FDA FAERS reports mention Rheumatoid arthritis. 91,026 reports have a serious outcome flag.
Medicines named as suspect
- Etanercept: 46,709 reports
- Adalimumab: 35,320 reports
- Methotrexate: 30,328 reports
- Abatacept: 23,201 reports
- Tocilizumab: 21,568 reports
- Leflunomide: 21,528 reports
- Rituximab: 21,063 reports
- Hydroxychloroquine: 20,853 reports
- Certolizumab Pegol: 18,983 reports
- Infliximab: 17,634 reports
- Sulfasalazine: 15,602 reports
- Golimumab: 12,845 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.